Christopher Gasparis: Anticoagulation After Atrial Fibrillation Ablation – Long-Term Impact on Stroke
Christopher Gasparis, Surgery Resident at Northwell Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Heart Rhythm O2, adding:
“Excited to share our new ITHACA database publication in Heart Rhythm O2!
We investigated the long-term risk of stroke in select patients with elevated CHA2DS2-VASc score who discontinued anticoagulation following atrial fibrillation ablation.
A big thank you to my mentors Stavros Mountantonakis and Kristie Coleman and my coauthors Stefanos Zafeiropoulos, Jonas Leavitt, Elliot Wolf, Ari Zimmer, Rajat Goyal and Dr. Laurence Epstein for their guidance and contributions.”
Title: Anticoagulation Decision Based on Atrial Fibrillation Ablation Outcomes and Long-Term Impact on Stroke. An ITHACA Database Study
Authors: Christopher Gasparis, Stefanos Zafeiropoulos, Jonas Leavitt, Elliot Wolf, Ari Zimmer, Rajat Goyal, Laurence M. Epstein, Kristie M. Coleman, Stavros E. Mountantonakis.

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C